Karin H. Karlsson

Suggest Changes
Learn More
BACKGROUND Allogeneic stem cell transplantation (alloSCT) reduces relapse rates in acute leukemia, but outcome is hampered by toxicity. Population-based data avoid patient selection and may therefore(More)